Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC-MPS with Reduced vs Reference Tacrolimus in Renal Transplant
NCT00229138Phase 4Completed
- Sponsor
- Novartis
- Start
- Sep 2005
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate sodium in kidney transplant rejection, sponsored by Novartis. Started Sep 2005; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00229138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00229138.